Cargando…

Does the timing of cabergoline administration impact rates of ovarian hyperstimulation syndrome?

OBJECTIVE: Does the timing of cabergoline administration impact the rate of mild/moderate ovarian hyperstimulation syndrome in women with a GnRH agonist trigger? METHODS: We conducted a retrospective cohort analysis of 285 in-vitro fertilization patients at risk of OHSS who received a GnRH agonist t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rubenfeld, Eryn Sara, Dahan, Michael Haim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Obstetrics and Gynecology 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290150/ https://www.ncbi.nlm.nih.gov/pubmed/34102744 http://dx.doi.org/10.5468/ogs.21067

Ejemplares similares

The Effectiveness of Cabergoline for the Prevention of Ovarian Hyperstimulation Syndrome
por: Hosseini, Marzieh Agha, et al.
Publicado: (2011)

Comparison of albumin and cabergoline in the prevention of ovarian hyperstimulation syndrome: A clinical trial study
por: Torabizadeh, Aalie, et al.
Publicado: (2013)

High Dose Cabergoline in Management of Bilateral Ovarian Hyperstimulation Syndrome: A Case Report
por: Manalai, Gulparkha, et al.
Publicado: (2021)

GnRH antagonist rescue protocol combined with cabergoline versus cabergoline alone in the prevention of ovarian hyperstimulation syndrome: a randomized controlled trial
por: Fouda, Usama M., et al.
Publicado: (2016)

Calcium gluconate infusion is as effective as the vascular endothelial growth factor antagonist cabergoline for the prevention of ovarian hyperstimulation syndrome
por: Naredi, Nikita, et al.
Publicado: (2013)

Comparison of Cabergoline and Quinagolide in Prevention of Severe Ovarian Hyperstimulation Syndrome among Patients Undergoing Intracytoplasmic Sperm Injection
por: Taheripanah, Robabeh, et al.
Publicado: (2018)

Evaluation of intravenous hydroxylethyl starch, intravenous albumin 20%, and oral cabergoline for prevention of ovarian hyperstimulation syndrome in patients undergoing ovulation induction
por: Ghahiri, Ataollah, et al.
Publicado: (2015)

Cabergoline for preventing ovarian hyperstimulation syndrome in women at risk undergoing in vitro fertilization/intracytoplasmic sperm injection treatment cycles: A randomized controlled study
por: Kılıç, Niyazi, et al.
Publicado: (2015)

Ovarian hyperstimulation syndrome
por: Kumar, Pratap, et al.
Publicado: (2011)

Large-Volume Paracentesis, up to 27 L, With Adjuvant Vaginal Cabergoline in the Case of Severe Ovarian Hyperstimulation Syndrome with Successful Pregnancy Outcome: A Case Report
por: Agarwal, Nupur, et al.
Publicado: (2017)

Early onset ovarian hyperstimulation syndrome despite use of segmentation approach and ovarian hyperstimulation syndrome prophylaxis
por: Mahajan, Nalini, et al.
Publicado: (2015)

Ovarian Hyperstimulation Syndrome, the Master of Disguise?
por: Ironside, Emily Charlotte, et al.
Publicado: (2015)

Effects of Cabergoline administration on uterine perfusion in women with polycystic ovary syndrome
por: Mohammadbygi, Robabeh, et al.
Publicado: (2013)

COVID-19 pandemic effect on early pregnancy: are miscarriage rates altered, in asymptomatic women?
por: Rotshenker-Olshinka, Keren, et al.
Publicado: (2020)

COVID-19 PANDEMIC EFFECT ON EARLY PREGNANCY – ARE MISCARRIAGE RATES ALTERED, IN ASYMPTOMATIC WOMEN?
por: Olshinka, Keren Rotshenker, et al.
Publicado: (2020)

Ovarian and intellectual hyperstimulation
por: Quaas, Alexander M.
Publicado: (2021)

Ovarian Hyperstimulation Syndrome as an Etiology of Obstructive Uropathy
por: Marak, Creticus P., et al.
Publicado: (2013)

Radiological Illustration of Spontaneous Ovarian Hyperstimulation Syndrome
por: Mittal, Kartik, et al.
Publicado: (2015)

Prevention of Ovarian Hyperstimulation Syndrome: A Review
por: Smith, Vinayak, et al.
Publicado: (2015)

Immunoglobulin Treatment in Severe Ovarian Hyperstimulation Syndrome
por: Gómez, Gemma Grau, et al.
Publicado: (2019)

Does the serum E2 level change following coasting treatment strategy to prevent ovarian hyperstimulation syndrome impact cycle outcomes during controlled ovarian hyperstimulation and in vitro fertilization procedure?
por: Yumuşak, Ömer Hamid, et al.
Publicado: (2014)

Kallistatin prevents ovarian hyperstimulation syndrome by regulating vascular leakage
por: Huang, Jianfang, et al.
Publicado: (2022)

Aflibercept suppresses ovarian hyperstimulation syndrome: an experimental study in rats
por: Ateş, Çağlayan, et al.
Publicado: (2023)

Ovarian hyperstimulation syndrome (OHSS) at a maternity hospital
por: Lappas, V, et al.
Publicado: (1999)

Severe ovarian hyperstimulation syndrome leading to ICU admission
por: Singh, R. K., et al.
Publicado: (2010)

Ovarian hyperstimulation syndrome- an optimal solution for an unresolved enigma
por: Orvieto, Raoul
Publicado: (2013)

Nephrotic Sydrome Developing in Severe Ovarian Hyperstimulation Syndrome
por: Gungor Ugurlucan, Funda, et al.
Publicado: (2014)

GnRH Analogues in the Prevention of Ovarian Hyperstimulation Syndrome
por: Alama, Pilar, et al.
Publicado: (2013)

Management of severe ovarian hyperstimulation syndrome with thawed plasma
por: Kamath, Mohan S, et al.
Publicado: (2013)

Spontaneous Ovarian Hyperstimulation Syndrome in a Triplet Pregnancy
por: Agrawal, Nisha Rani, et al.
Publicado: (2012)

Ovarian hyperstimulation syndrome in a spontaneous singleton pregnancy
por: Cabar, Fábio Roberto
Publicado: (2016)

Spontaneous ovarian hyperstimulation syndrome: Report of two cases
por: Gui, Juan, et al.
Publicado: (2019)

Chorionic gonadotropin: Ovarian hyperstimulation syndrome: case report
Publicado: (2021)

Spontaneous Ovarian Hyperstimulation Syndrome Associated With Primary Hypothyroidism
por: Alzebidi, Jawharah A, et al.
Publicado: (2023)

Clinical Features of Severe Ovarian Hyperstimulation Syndrome with Hydrothorax
por: Ma, Xiaowei, et al.
Publicado: (2023)

Outcomes of assisted reproduction treatment after dopamine agonist -cabergoline- for prevention of ovarian hyper stimulation syndrome
por: Movahedi, Shohreh, et al.
Publicado: (2016)

Ovarian cyst regression with levothyroxine in ovarian hyperstimulation syndrome associated with hypothyroidism
por: Langroudi, Roghieh Molaei, et al.
Publicado: (2013)

Gonadotropin releasing hormone antagonist administration for treatment of early type severe ovarian hyperstimulation syndrome: a case series
por: Lee, Dayong, et al.
Publicado: (2017)

Prediction of ovarian hyperstimulation syndrome in coasted patients in an IVF/ICSI program
por: Aljawoan, Fatimah Y, et al.
Publicado: (2012)

A new effective method in the treatment of severe ovarian hyperstimulation syndrome
por: Zhang, Qingrui, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_f54egrhb6v6a1fb6q0fbp8ghr6